Clinical Trials in Maryland

Showing 5921-5940 of 17,687 trials

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

NCT01355679

The purpose of this study is to test the feasibility (ability to be done) of an experimental test to help plan your cancer treatment. This study plan is not studying the effectiveness of the proposed combinations of therapy for your cancer that you may receive after the experimental testing. This study will look at an experimental technology to determine a tumor's molecular makeup (gene expression profile). This technology (called "OncInsights") is being used to discover new ways to understand cancers and potentially predict the best treatments for patients with cancer in the future. The experimental technology has not been approved by the U.S. Food and Drug Administration.

Neuroblastoma

Giselle Sholler16 participantsStarted May 2011

Hartford, Connecticut, United States • Orlando, Florida, United States • Bethesda, Maryland, United States +4 more locations

COMPLETEDPhase 219 miles

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

NCT05409235

This study will evaluate the safety and efficacy of OTT166 Ophthalmic solution in participants with Diabetic Retinopathy.

Diabetic Retinopathy

OcuTerra Therapeutics, Inc.225 participantsStarted Jul 2022

Peoria, Arizona, United States • Phoenix, Arizona, United States • Beverly Hills, California, United States +65 more locations

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Find Trials by Condition in Maryland

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Voxelotor Brain Oxygenation and Neurocognitive Study

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Training for Health Professionals In Tanzania

Microwave Treatment for Actinic Keratosis